Compound library / Cognitive / Nootropic

Adamax (N-Acetyl Semax Amidate)

Acetylated and amidated analogue of Semax, marketed as a longer-acting, more potent next-generation Semax derivative for cognitive enhancement; sometimes listed in databases as "ADAMAX/Semax." Independent clinical data is essentially absent.

CategoryCognitive / Nootropic
Regulatory standingNo approved product cited
Typical routeNasal
Half-lifeNot independently well characterized
Common dose rangeResearch-stage; typically 50-200 mcg/day as nasal spray
Typical cycle length2-4 weeks on / break

BioHack Track models Adamax (N-Acetyl Semax Amidate) at a half-life of 0.5 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.

No approved product cited

No FDA-approved product for this compound is cited on this page, and no approved human dose is quoted. Treat the range below as research and community practice rather than a prescribed dose.

Reconstitution

Often supplied pre-mixed as nasal spray.

Storage

Refrigerate.

Cautions

Vendor-marketed "improved" analogue with little to no independent verification — treat efficacy claims skeptically.

Track Adamax (N-Acetyl Semax Amidate) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.

Others in Cognitive / Nootropic

Look up the research

These open a search of each database for Adamax (N-Acetyl Semax Amidate) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.

Work it out

Where these figures come from

The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.

These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.

Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.

Published by Creative Images LLC · Last updated · Corrections: support